Why Johnson & Johnson (JNJ) Stock Declined Despite Strong Q2 Earnings Beat
TLDR Johnson & Johnson delivered Q2 adjusted EPS of $2.90, surpassing analyst expectations of $2.85 Second-quarter revenue reached $25.31 billion, representing 6.6% year-over-year growth and




